Company profile for Tolremo therapeutics

Tolremo Therapeutics

NEW Drugs in Dev: 1

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

pharmacompass-2-2026-02-09

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

10 News #PharmaBuzz

media
10 News #PharmaBuzz

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At TOLREMO, we address non-genetic cancer drug resistance to transform targeted treatment regimens into long-term therapeutic solutions. By targeting early transcriptional reprogramming, cancer's first defense to targeted treatments, our goal is to prevent therapy evasion before it occurs. We are advancing our lead compound as a critical component of success for a wide range of targeted treatment regimens, including the curren...

At TOLREMO, we address non-genetic cancer drug resistance to transform targeted treatment regimens into long-term therapeutic solutions. By targeting early transcriptional reprogramming, cancer's first defense to targeted treatments, our goal is to prevent therapy evasion before it occurs. We are advancing our lead compound as a critical component of success for a wide range of targeted treatment regimens, including the current standard of care as well as future cancer therapies.

Clinical OutsourcingClinical Outsourcing

Not Confirmed

Not Confirmed

03-04 March, 2026

Copthorne Tara Hotel, London Kensington, United Ki
Natural Product Expo W...Natural Product Expo West

Not Confirmed

Not Confirmed

03-06 March, 2026

California, U.S.A
Natural Products ExpoNatural Products Expo

Not Confirmed

Not Confirmed

03-06 March, 2026

California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Switzerland Flag

Country

Country

Switzerland

Address

Address

Hochbergerstrasse 60C CH-4057 Basel

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.tolremo.com/

Linkedin

https://www.linkedin.com/company/tolremo-therapeutics/

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

TOLREMO Pharma Adds Myeloma Expert Anderson To Advisory Board

30 Oct 2025

// GLOBENEWSWIRE

Tolremo Completes First Human Dose Escalation for TT125-802

17 Oct 2025

// GLOBENEWSWIRE

Tolremo Therapeutics Granted Dual FDA Fast Track Status

28 Aug 2025

// GLOBENEWSWIRE

TOLREMO therapeutics Announces Strengthening of Leadership

18 Jun 2025

// GLOBENEWSWIRE

TOLREMO’s TT125-802 Shows First CBP/p300 Activity in Solid Tumors

04 Jun 2025

// GLOBENEWSWIRE

TOLREMO Adds Lung Cancer Expert Pasi A. to Advisory Board

25 Mar 2025

// BUSINESSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search